Biotechs Sign Big Lease for Lab Space in Watertown Square

In the largest lease deal for newly-built lab space so far this year, The Davis Companies and Boston Development Group (BDG) have entered into lease agreements with life sciences firms LifeMine Therapeutics and a new stealth-mode biotech (NewCo) for space in the brand-new, purpose-built, 225K square-foot, Class A life science building at 66 Galen Street in Watertown Square. The new tenants will occupy more than half of the building’s leasable space.

LifeMine, a biopharm leveraging “evolutionary insights from fungi to unearth next-generation precision medicines,” will fully occupy the 56,456 square-foot fourth floor. Stealth-mode NewCo, well-funded by elite life-science venture firms, will occupy the third floor, comprised of 61,189 square feet. Both companies operate under the leadership of biotech pioneer and serial life science entrepreneur Greg Verdine, Co-founder and CEO of LifeMine and Co-founder of NewCo.

The strategic decision to move both LifeMine and the stealth NewCo under the same roof is expected to foster ideas and accelerate the pace of innovation. The proximity to the Greater Boston life science cluster will also support talent recruitment efforts. (Source: The Davis Companies Website, 03 October, 2024)|